Loading…
for educational and safety purposes
sci-wiki~$open stack lipid-control
a steep evidence gradient, and pretending otherwise would be the useless version
4 items; 3 structures drawn from pubchem, 1 drawn generically because pubchem has no record of the name.
⚠️ THE HONEST SHAPE OF THIS STACK IS A STEEP EVIDENCE GRADIENT, AND SMOOTHING IT WOULD BE THE MOST HARMFUL THING THIS PAGE COULD DO. Presenting four items as one stack invites a reader to treat them as equals. They are not, and saying so is the most useful sentence here.
Ezetimibe is an approved drug with hard cardiovascular outcome data behind it, from IMPROVE-IT. It blocks intestinal cholesterol absorption at NPC1L1, a completely different mechanism from a statin, which is exactly why the two combine well.
Tirzepatide or retatrutide are incretin agonists and approved drugs with strong metabolic data. Most of their lipid improvement is driven by the weight loss itself, with direct metabolic effects on top. Tirzepatide is the better-tolerated of the two on current reports.
⚠️ CINNAMON'S SPECIES QUESTION IS A SAFETY POINT RATHER THAN PEDANTRY. Cassia cinnamon contains coumarin, which has hepatotoxic potential at habitual intakes; Ceylon cinnamon contains very little. Most supermarket cinnamon is cassia. Its lipid and glycaemic effects, meanwhile, are small and frequently null in meta-analysis, so the risk-to-benefit reasoning is not favourable in the way people assume.
Chromium picolinate is included because it was asked for, and the honest description is that evidence for lipid or glycaemic benefit in people without deficiency is weak and largely null. Marked optional for that reason.
The honest structure is two items that work and two that are included because they were asked for, and describing them as one coordinated stack would misrepresent it.
Ezetimibe and the incretin do genuinely complement each other, and mechanically the pairing is clean. Ezetimibe blocks intestinal cholesterol absorption at NPC1L1, reducing what enters the body; the incretin reduces adiposity, and weight loss changes hepatic lipid handling, triglycerides and HDL through a completely separate route. Absorption and production, addressed independently.
Ezetimibe also pairs unusually well with a statin for the same structural reason, since a statin reduces synthesis while ezetimibe reduces absorption, and the body's compensatory response to one is partly blocked by the other. That is why the combination has outcome data behind it.
Cinnamon and chromium picolinate do not meaningfully add to that. Their lipid and glycaemic effects are small, inconsistent and repeatedly null in meta-analysis, and both are marked optional.
Nothing, from the lipid changes themselves. Lipids are a number on a blood test and have no perceptual correlate, which is the whole reason this stack has to be judged on bloodwork rather than on how anyone feels.
The incretin is the exception and is felt as reduced appetite within the first week.
The useful timescale is six to twelve weeks to a repeat lipid panel, and that panel is the only honest readout.
⚠️ CASSIA CINNAMON CONTAINS COUMARIN, WHICH IS HEPATOTOXIC AT HABITUAL DOSES, and most cinnamon sold is cassia rather than Ceylon; this is the one genuine safety issue in the roster. Ezetimibe and the incretins are prescription drugs. GLP-1 agonists carry gastrointestinal effects, a pancreatitis signal and a rodent thyroid C-cell warning. Lipid management is one of the few areas here where a doctor and a blood test are straightforwardly available, and using them is the sensible route.
nothing flaggedcurated roster
every pair here reads as compatible on the mechanisms the site holds. that is the absence of a known conflict, not a clearance.
2 of 4 in one basketPCT.Zone; Code Scientific
3 of 4 priced
1 of these carry no listed price, so there is no honest total to print; the lines above are what can actually be costed.
no overlap found
no two of these share a primary class or a listed receptor. every item is pulling a different lever.
interested in protocols? join the discord; that is where dosing, timing and the practical side get discussed.
the sci-wiki publishes this as a description of what these compounds do together, not as a recommendation to take them. Nothing here is medical advice.